749 related articles for article (PubMed ID: 9440748)
1. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
[TBL] [Abstract][Full Text] [Related]
2. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S; Haase G; Ritchey M; Kelalis P; D'Angio GJ
J Clin Oncol; 1998 Dec; 16(12):3744-51. PubMed ID: 9850017
[TBL] [Abstract][Full Text] [Related]
3. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Beckwith JB; Breslow NE; Faria P; Moksness J; Finklestein JZ; Grundy P; Thomas PR; Kim T; Shochat S
J Clin Oncol; 1994 Oct; 12(10):2126-31. PubMed ID: 7931483
[TBL] [Abstract][Full Text] [Related]
4. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
[TBL] [Abstract][Full Text] [Related]
5. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
[TBL] [Abstract][Full Text] [Related]
6. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
Pritchard J; Imeson J; Barnes J; Cotterill S; Gough D; Marsden HB; Morris-Jones P; Pearson D
J Clin Oncol; 1995 Jan; 13(1):124-33. PubMed ID: 7799012
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM
Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918
[TBL] [Abstract][Full Text] [Related]
8. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
9. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
[TBL] [Abstract][Full Text] [Related]
10. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Green DM; Breslow NE; Evans I; Moksness J; D'Angio GJ
Med Pediatr Oncol; 1996 Mar; 26(3):147-52. PubMed ID: 8544795
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
12. Relationship between dose schedule and charges for treatment on National Wilms' Tumor Study-4. A report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Evans I; Moksness J; Finklestein JZ; Evans AE; D'Angio GJ
J Natl Cancer Inst Monogr; 1995; (19):21-5. PubMed ID: 7577200
[TBL] [Abstract][Full Text] [Related]
13. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Moksness J; Finklestein JZ; D'Angio GJ
J Clin Oncol; 1994 Oct; 12(10):2132-7. PubMed ID: 7931484
[TBL] [Abstract][Full Text] [Related]
14. The effect of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms' tumor. A report from the National Wilms' Tumor Study.
Green DM; Breslow NE; Evans I; Moksness J; Finklestein JZ; Evans AE; D'Angio GJ
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):207-12. PubMed ID: 8037337
[TBL] [Abstract][Full Text] [Related]
15. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
[TBL] [Abstract][Full Text] [Related]
16. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
[TBL] [Abstract][Full Text] [Related]
17. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.
Green DM; Norkool P; Breslow NE; Finklestein JZ; D'Angio GJ
J Clin Oncol; 1990 Sep; 8(9):1525-30. PubMed ID: 2167951
[TBL] [Abstract][Full Text] [Related]
18. Better survival after combined modality care for adults with Wilms' tumor. A report from the National Wilms' Tumor Study.
Arrigo S; Beckwith JB; Sharples K; D'Angio G; Haase G
Cancer; 1990 Sep; 66(5):827-30. PubMed ID: 2167146
[TBL] [Abstract][Full Text] [Related]
19. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
